Over 47 percent antibiotic formulations used in India in 2019 unapproved: Lancet
Advertisement
More than 47 percent of antibiotic formulations used in India's private sector in 2019 were not approved by the central drug regulator, according to a study published in The Lancet Regional Health Southeast Asia.
The research also found that azithromycin 500mg tablet was the most consumed antibiotic formulation (7.6 percent) in India, followed by cefixime 200 mg tablet (6.5 percent) during the year.
The researchers at Boston University, US, and Public Health Foundation of India, New Delhi, examined the private sector antibiotic use, which contributes to 85-90 percent of the total consumption in India.
For more details, check out the link given below:
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.